(Q42923271)

English

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

scientific article published on September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 November 2017

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial (English)

1 reference

Europe PubMed Central

11 November 2017

0 references

0 references

chronic heart failure

1 reference

based on heuristic

inferred from title

8

object named as

Luigi Tavazzi

1 reference

Europe PubMed Central

11 November 2017

3

object named as

Michel Komajda

1 reference

Europe PubMed Central

11 November 2017

2

object named as

Karl Swedberg

1 reference

Europe PubMed Central

11 November 2017

author name string

Michael Böhm

1

1 reference

Europe PubMed Central

11 November 2017

Jeffrey S Borer

4

1 reference

Europe PubMed Central

11 November 2017

Ian Ford

5

1 reference

Europe PubMed Central

11 November 2017

Ariane Dubost-Brama

6

1 reference

Europe PubMed Central

11 November 2017

Guy Lerebours

7

1 reference

Europe PubMed Central

11 November 2017

SHIFT Investigators

9

1 reference

Europe PubMed Central

11 November 2017

language of work or name

0 references

publication date

1 September 2010

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

376

1 reference

Europe PubMed Central

11 November 2017

886-894

1 reference

Europe PubMed Central

11 November 2017

9744

1 reference

Europe PubMed Central

11 November 2017

Heart rate and cardiovascular mortality: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of mortality and morbidity in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Retarding effect of lowered heart rate on coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart rate correlates with severity of coronary atherosclerosis in young postinfarction patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

BEAUTIFUL results--the slower, the better?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Altered myocardial force-frequency relation in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Graded Heart Rate Reduction with Ivabradine on Myocardial Oxygen Consumption and Diastolic Time in Exercising Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Resting heart rate in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective arterial elastance as index of arterial vascular load in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of heart rate on mechanical dyssynchrony and left ventricular contractility in patients with heart failure and normal QRS duration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining the optimum upper heart rate limit during exercise: a study in pacemaker patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart rate per se impacts cardiac function in patients with systolic heart failure and pacing: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-blockers in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of beta-adrenergic receptor desensitization: from molecular biology to heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961259-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)61259-7

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42923271&oldid=1973881571"